A Multi-center, Open Label Extension Study to Evaluate the Safety of an Oral Dose of Tranexamic Acid (XP12B) Administered Three Times Daily During Menstruation for the Treatment of Menorrhagia.

Trial Profile

A Multi-center, Open Label Extension Study to Evaluate the Safety of an Oral Dose of Tranexamic Acid (XP12B) Administered Three Times Daily During Menstruation for the Treatment of Menorrhagia.

Completed
Phase of Trial: Phase III

Latest Information Update: 15 Oct 2011

At a glance

  • Drugs Tranexamic acid (Primary)
  • Indications Menorrhagia
  • Focus Adverse reactions
  • Sponsors Ferring Pharmaceuticals
  • Most Recent Events

    • 15 Oct 2011 Results presented at the 67th Annual Meeting of the American Society for Reproductive Medicine.
    • 08 Feb 2011 New trial record
    • 25 Oct 2010 Results presented at the 66th Annual Meeting of the American Society for Reproductive Medicine.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top